Special Considerations in the Management of Women With HIV, Including Management of Conception and Pregnancy

  • Author: Kristine Patterson, MD (More Info)
  • Section Editor: Judith S. Currier, MD, MSc
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/5/18 (What's New)

Summary

  • Guidelines on opportunistic infections recommend testing for latent TB infection at HIV diagnosis and annually thereafter in HIV-infected women with an ongoing risk for acquiring TB (Management Guidelines)[CDC OI]
  • Testing may be repeated in patients whose CD4+ cell count was < 200 cells/mm3 at initial screening but is ≥ 200 cells/mm3 on ART[CDC OI]
  • WHO guidelines recommend that HIV-infected patients in resource-constrained settings should be screened for TB at each clinical interaction (Management Guidelines)[WHO HIV]

Action required

Keywords: Biomedical Prevention, Tuberculosis, Varicella Zoster Virus , Viral Hepatitis Coinfection, Women

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.